Skip to main content
VTRS logo
VTRS
(NASDAQ)
Viatris Inc.
$13.44-- (--)
Loading... - Market loading

Viatris (VTRS) Stock Price & Financial Analysis

Viatris Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$13.28 - $13.65
52-Week High$16.47
52-Week Low$6.85
Open$13.31
Volume5.84M
Average Volume (3M)5.84M
Market Cap15.49B
Shares Outstanding1.15B
Price to Sales (P/S)1.10
Price to Book (P/B)1.07
EV/EBITDA-73.50
Revenue (TTM)14.30B
Net Income (TTM)-3.51B
Free Cash Flow (TTM)1.82B
EPS (TTM)$-3.05
Profit Margin-24.58%
Operating Margin1.02%
Return on Equity (ROE)-23.89%
Debt to Equity1.00
50-Day MA$14.29
200-Day MA$11.35
52-Week Change58.49%
Annual Dividend$0.48
Dividend Yield3.52%
Last Dividend Ex-DateMar 9, 2026

Frequently Asked Questions About Viatris

What is the current stock price for VTRS?

As of the latest trading session, VTRS stock trades at $13.44. The 52-week range is $6.85–$16.47, with a day range of $13.28–$13.65.

What is the P/E ratio for VTRS?

The P/E ratio (Price-to-Earnings) for VTRS is shown in the Key Statistics section. This valuation metric helps compare Viatris Inc. to industry peers.

Does VTRS pay dividends?

Yes, Viatris pays a 3.52% annual dividend yield ($0.48 per share). The last ex-dividend date was 2026-03-09.

What do analysts recommend for VTRS?

Based on 2 analysts, the consensus for VTRS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of VTRS?

Viatris's market capitalization is $15.49B, classifying it as a large-cap company. Viatris operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.